AQUIT

Founded: 2017 • Age: 9 yrs
Develops preventive treatments for fish infections using biotechnology and immunity boosters.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 8 Brand Intelligence

About AQUIT

AQUIT is a company founded in 2017. It operates as a B2B. AQUIT offers products and services including Preventive Treatment and Bioinformatic and AI Platform. AQUIT operates in a competitive market with competitors including Benchmark Holdings, PatoGen, Essential Aquatech, Salmokine and Anjana Sterilants, among others.

  • Sectors
    Agriculture
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Agriculture → Aquaculture & Fisheries Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AQUIT

AQUIT offers a comprehensive portfolio of products and services, including Preventive Treatment and Bioinformatic and AI Platform.

Product name locked
Category locked
Primary

Reproduces proteins to boost fish immunity against infections.

Product name locked
Category locked
Locked

Identifies proteins for physiological processes in various species.

Funding Insights of AQUIT

Premium access

Detailed funding history for AQUIT

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AQUIT

Investments
Premium access

Investment portfolio details for AQUIT

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - AQUIT

Premium access

Detailed financials for AQUIT

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aquit Comparisons

AQUIT Primary company
Description
Develops preventive treatments for fish infections using bio...
Location
-
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for AQUIT

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of AQUIT

AQUIT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benchmark Holdings, PatoGen, Essential Aquatech, Salmokine and Anjana Sterilants, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Advanced nutrition and health solutions for aquaculture are provided.
Locked Locked Locked
Infections and diseases in aquaculture are predicted via genetic analysis.
Locked Locked Locked
Offers 24x7 aquaculture support, fish feed, medicines, and sustainable technologies.
Locked Locked Locked
Biotech solutions and services for aquaculture are provided.
Locked Locked Locked
Manufactures high-quality sterilization products and disinfectants for the aquaculture industry.
Locked Locked Locked
Offers diagnostic services and products for aquatic health in aquaculture sectors.
Premium access

Detailed competitors of AQUIT

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aquit

Premium access

Complete news archive for AQUIT

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AQUIT

AQUIT was founded in 2017.

AQUIT focuses on biotechnology to create preventive treatments that replace antibiotics in aquaculture, improving fish survival rates and natural immunity. They reproduce key proteins to combat infections without harmful effects, as demonstrated in trials with Chilean Salmon. Based in Chile, the company conducts research and develops AI platforms for broader species, targeting the aquaculture industry to reduce losses and promote sustainability.

AQUIT's top competitors include Benchmark Holdings, PatoGen and Salmokine.

AQUIT offers Preventive Treatment and Bioinformatic and AI Platform.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available